Showing 291-300 of 9128 results for "".
Targeting Tech Neck
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/targeting-tech-neck/19617/Today’s tech-obsessed population is always looking down at devices, creating lines and wrinkles in the neck. Kim Nichols, MD describes the problem of Tech Neck and the regimen she uses to treat it.Maximize the marketing benefits of new dermatology devices
https://practicaldermatology.com/topics/practice-management/maximize-the-marketing-benefits-of-new-dermatology-devices/18354/New equipment and devices can mean new patients pouring through the doors of your dermatology office – but only if you market them effectively. Check out this Ekwa Marketing educational video to find out the best way to spread the word, and what marketing pitfalls to avoid.Introduction to Nutraceuticals
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/introduction-to-nutraceuticals/18438/What are nutraceuticals and what role may they play in surgical outcomes? Why should aesthetic surgeons care about nutrition? Jason Bloom, MD discusses the rationale behind nutraceuticals to support surgical outcomes and describes his observations after recommending a formulation to his patients.Improving Outcomes with Neuromodulators
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/improving-outcomes-with-neuromodulators/18521/Joel L. Cohen, MD offers treatment tips for best, natural outcomes with neuromodulator injections. He also discusses how injecting toxins prior to resurfacing or prior to filler injections can improve results and duration of effects.Neurotoxin Tips and Trends
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/neurotoxin-tips-and-trends/18743/The latest trends in aesthetic dermatology call for a more natural look. Dr. Rossi says dermatologists are injecting less units of neurotoxins, more strategically placed for a more cosmetically pleasing look. He stresses the need to think about neuromodulation rather than paralyzing the muscles to aDerm Insider: Navigating Office Politics
https://practicaldermatology.com/topics/practice-management/derm-insider-navigating-office-politics/18993/In this edition of Derm Insider, host Neal Bhatia, MD speaks with practice management experts about the complex inner workings of an office environment, as well as the role of physicians in managing precarious situations regarding employees. Offering advice for maneuvering these situations, guests SMerz Acquires Ulthera; Ulthera Gets Decolletage Indication, and a New Topical for Onychomycosis
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-merz-acquires-ulthera-ulthera-gets-decolletage-indication-and-a-new-topical-for-onychomycosis/19117/In this edition of DermWireTV, from the publishers of Practical Dermatology® magazine, learn the latest on the Merz/Ulthera acquisition, a new topical for toenail fungus, and FDA accepts Kythera's NDA.Psoriasis Pipeline Update: JNJ-2113, A Novel Oral IL-23 Receptor Antagonist Peptide, Shows Promise in a Phase 2b Study
https://practicaldermatology.com/topics/psoriasis/psoriasis-pipeline-update-jnj-2113-a-novel-oral-il-23-receptor-antagonist-peptide-shows-promise-in-a-phase-2b-study/20207/Laura Korb Ferris, MD, PhD, discusses the topline results from a Phase 2b trial of JNJ-2113, a novel oral IL-23 receptor antagonist peptide that’s being developed for moderate-to-severe plaque psoriasis.FDA Approves New Drug for Prurigo Nodularis; Long-Term Use of Dupilumab Examined
https://practicaldermatology.com/series/dermwire-tv/fda-approves-new-drug-prurigo-nodularis-long-term-use-dupilumab-examined/26925/In this week's DermwireTV, the FDA approves Galderma's Nemluvio for adults with prurigo nodularis; a study examines the long-term use of dupilumab for atopic dermatitis; and Andrew Mastro discusses how to talk to patients about starting a Janus kinase (JAK) inhibitor for AD.On New Therapeutics and Real Sushi
https://practicaldermatology.com/series/the-practical-dermatology-podcast/on-new-therapeutics-and-real-sushi/32849/The latest news and updates, plus E. James Song, MD, FAAD, joins Practical Dermatology Associate Medical Editor Lisa Swanson, MD, FAAD, to discuss the 2025 outlook for new therapeutics and play "Two Truths and a Lie." Dr. Song says he has been a wrestler, a jazz musician, and a sushi che